Auris Medical has reported topline data from its Phase 2 Travers trial with intranasal betahistine in vertigo.
In a new report on antibiotic-resistant germs, the CDC highlights the rising levels of risk and what we must do to control the risk of spreading these germs.
Johnson & Johnson is scheduled to release its first-quarter financial results before the markets open on Tuesday, and expectations are muted.
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
GE agrees to a rich pay package for its new CEO, Toyota announces a huge recall, bond yields hit levels not seen since 2011, and other important business headlines.
Gogo, Auris Medical, Nevro Corp., and Invesco all posted new 52-week lows Friday.
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Companies hitting lows and punishing shareholders when the market is hitting all-time highs are not exactly winning the hearts and minds of the investing community.
August 18, 2016: Here are four stocks trading with relatively heavy volume among 33 equities making new 52-week lows in Thursday’s session. NYSE advancers led decliners by about 2 to 1 and...
On Thursday, a few companies in the biotech and pharmaceutical industries made substantial runs. In this case it was all downward.
Source: ThinkstockThere are just five initial public offerings (IPOs) on the calendar for the coming week, and one is a holdover from last week. The seven IPOs that were completed last week posted a...
Source: ThinkstockThe 22 initial public offerings (IPO) that were originally scheduled for last week added up to the highest total since 2000. The week ahead won’t match that, but it’s another...
Source: ThinkstockWe have counted 22 initial public offerings (IPOs) on the schedule for this week, including just two holdovers from last week. Of the dozen companies that actually made it to the...